Pharmaceutical - Antibiotics and Infectious diseases

Filter

Popular Filters

201 to 225 of 229 results

Common antifungal drug thiabendazole shows promise as cancer therapy

21-08-2012

An inexpensive US Food and Drug Administration approved antifungal drug, thiabendazole, slows tumor growth…

Antibiotics and Infectious diseasesOncologyPharmaceuticalResearchthiabendazole

AstraZeneca/BTG abandon CytoFab for sepsis as it fails in Ph IIb

09-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has decided to halt any further development of AZD9773…

Antibiotics and Infectious diseasesAstraZenecaBTGCytoFabLicensingPharmaceuticalResearch

BioAlliance Pharma out-licenses Oravig to Vestiq Pharma for the USA

22-07-2012

BioAlliance Pharma out-licenses Oravig to Vestiq Pharma for the USA

Antibiotics and Infectious diseasesBioAlliance PharmaLicensingLoramycNorth AmericaOravigPharmaceuticalVestiq Pharmaceuticals

UK's NICE launches new medicines advisory service

15-07-2012

The UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) last Friday launched…

Antibiotics and Infectious diseasesAstellas PharmaBiotechnologyDificlirEuropeGenericsPharmaceuticalRegulation

Single silk device can store and deliver vaccine or antibiotic without costly cold chain

10-07-2012

Researchers at the USA-based Tufts University School of Engineering have discovered a way to maintain…

Antibiotics and Infectious diseasesPharmaceuticalResearchVaccines

Boehringer Ingelheim links with Harvard for unmet medical needs research

09-07-2012

Family-controlled German drug major Boehringer Ingelheim has established a translational research collaboration…

Antibiotics and Infectious diseasesBoehringer IngelheimOncologyPharmaceuticalResearch

TaiGen Biotech out-licenses China rights for nemonoxacin, to Zhejiang Medicine

26-06-2012

Taiwan-based TaiGen Biotechnology and China's Zhejiang Medicine Company (SHA: 600216) have signed an…

Antibiotics and Infectious diseasesAsia-PacificBiotechnologyLicensingnemonoxacinPharmaceuticalTaiGen BiotecnologyZhejiang Medicine

Cubist unveils five-year strategic goals; enters antibiotics collaboration

12-06-2012

USA-based Cubist Pharmaceuticals (Nasdaq: CBST) has announced its five-year strategic aspirations - Building…

Antibiotics and Infectious diseasesCubicinCubist PharmaceuticalsEnteregFinancialFundacion MEDINAPharmaceuticalResearch

Optimer earns 10 million-euro milestone as Astellas debuts Dificlir in Europe

11-06-2012

USA-Based Optimer Pharmaceuticals (Nasdaq: OPTR) says that it is set to receive 10 million euros ($12.5…

Antibiotics and Infectious diseasesAstellas PharmaDificlirEuropeFinancialLicensingOptimer PharmaceuticalsPharmaceutical

Positive Ph IIb results for Otsuka TB drug candidate delamanid

07-06-2012

Japanese drugmaker Otsuka Pharmaceutical (TYO: 4578) has announced Phase IIb clinical trial results on…

Antibiotics and Infectious diseasesdelamanidOtsukaPharmaceuticalResearchRespiratory and Pulmonary

Forest acquires rights to Nabriva antibacterial and option to buy firm

04-06-2012

US drugmaker Forest Laboratories (NYSE: FRX) says it has entered into an agreement with Austrian biotech…

Antibiotics and Infectious diseasesBC-3781BiotechnologyForest LaboratoriesLicensingMergers & AcquisitionsNabriva TherapeuticsPharmaceutical

Meiji Seika to expand in Russian pharmaceutical market

29-05-2012

Japanese drugmaker Meiji Seika Pharma has signed a partnership agreement with R-Pharm, one of Russia's…

Antibiotics and Infectious diseasesEuropeLicensingMarkets & MarketingMeiji Seika PharmaPharmaceuticalR-Pharma

News briefs: GlaxoSmithKline and Bayer

24-05-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) has said it would not proceed with its $2.59 billion hostile…

Antibiotics and Infectious diseasesBayerGlaxoSmithKlineMergers & AcquisitionsOncologyPharmaceuticalregorafenibRegulationResearch

Concerns over drug resistance in Gram-negative infections has led to changes in drug usage in USA

09-05-2012

Piperacillin-tazobactam is a leading and preferred therapy for Gram-negative infections (GNIs), accounting…

Antibiotics and Infectious diseasesMarkets & MarketingNorth AmericaPharmaceutical

ViroPharma stock plunges on bad news for Vancocin; Sanofi patents invalidated

11-04-2012

ViroPharma I (Nasdaq: VPHM) saw its shares plunge 19% to $23.25 yesterday after it announced that the…

Antibiotics and Infectious diseasesApotexGenericsHospiraLegalNorth AmericaOncologyPatentsPharmaceuticalRegulationSanofiTaxotereVancocinViroPharmaWatson Pharmaceuticals

Optimer Pharma could earn $90 million from new Astellas deal

30-03-2012

US firm Optimer Pharmaceuticals (Nasdaq: OPTR) has entered into a second deal with Japanese drug major…

Antibiotics and Infectious diseasesAsia-PacificAstellas PharmaDificidfidaxomicinLicensingOptimer PharmaceuticalsPharmaceutical

New pathway proposed for antibiotic approval in USA

09-03-2012

The US Congress will consider a new drug approval pathway to encourage development of critically needed,…

Antibiotics and Infectious diseasesNorth AmericaPharmaceuticalRegulationResearch

Daiichi Sankyo and Terumo link up for vaccine development

27-02-2012

Drug major Daiichi Sankyo (TYO: 4568) and fellow Japanese company Terumo Corp (TYO: 4543) have entered…

Antibiotics and Infectious diseasesDaiichi SankyoPharmaceuticalResearchTerumoVaccines

Additional indications in Japan for Diagnogreen and Sawacillin

22-02-2012

Japanese drug major Daiichi Sankyo (TYO: 4568) says it has received approval in Japan for a supplemental…

Antibiotics and Infectious diseasesAsia-PacificAstellas PharmaDaiichi SankyoPharmaceuticalRegulationSawacillin

Hospira challenges Cubist patents on Cubicin

10-02-2012

US drugmaker Cubist Pharmaceuticals (Nasdaq: CBST) says that it has received a Paragraph IV Notice Letter…

Antibiotics and Infectious diseasesCubicinCubist PharmaceuticalsGenericsHospiraNorth AmericaPatentsPharmaceuticalResearch

GlaxoSmithKline pauses four UTI drug trials

07-02-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) has voluntarily paused enrollment in its current clinical…

Anacor PharmaceuticalAntibiotics and Infectious diseasesGlaxoSmithKlinePharmaceuticalResearch

201 to 225 of 229 results

Back to top